CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Nibec Company Snapshot
Nibec operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nibec with three other pharmaceutical manufacturers in Asia: AnyGen Co Ltd (2015 sales of 3.72 billion Korean Won [US$3.17 million] ), Avon Organics Limited of India (290.55 million Indian Rupees [US$4.26 million] ), and Phong Phu Pharmaceutical JSC which is based in Vietnam (99.31 billion Dong [US$4.40 million] ).

Sales Analysis. Nibec reported sales of 4.17 billion Korean Won (US$3.55 million) for the year ending December of 2015. This represents a decrease of 12.8% versus 2014, when the company's sales were 4.79 billion Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Nibec
  Stock Performance Chart for Nibec
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 8,730.00
(Figures in Korean Won)
1 Week -1.5%   13 Weeks 6.2%  
4 Weeks -17.3%   52 Weeks -9.1%  
 
Nibec Key Data:
  Ticker: 138610 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2015 Sales 4,173,528,189
(Year Ending Jan 2016).
Employees: 31
  Currency: Korean Won Market Cap: 45,568,111,950
  Fiscal Yr Ends: December Shares Outstanding: 5,219,715
  Share Type: Common Closely Held Shares: 1,437,899
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.